Association of Patient Age With Progression of Low-risk Papillary Thyroid Carcinoma Under Active Surveillance

甲状腺癌 医学 肿瘤科 联想(心理学) 癌 乳头状癌 内科学 甲状腺 心理学 心理治疗师
作者
Alexandra Koshkina,Rouhi Fazelzad,Iwao Sugitani,Akira Miyauchi,Lehana Thabane,David Paul Goldstein,Sangeet Ghai,Anna M. Sawka
出处
期刊:JAMA otolaryngology-- head & neck surgery [American Medical Association]
卷期号:146 (6): 552-552 被引量:82
标识
DOI:10.1001/jamaoto.2020.0368
摘要

Importance: Active surveillance is sometimes considered as a disease management option for individuals with small, low-risk papillary thyroid carcinoma. Objective: To assess whether patient age is associated with progression of low-risk papillary thyroid carcinoma (tumor growth or incident metastatic disease) in adults under active surveillance. Evidence Review: Eight electronic databases (MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, Emcare, PsycINFO, Web of Science, and ClincalTrials.gov) were searched from inception to March 2019, supplemented with a hand search. Two investigators independently screened citations, reviewed full-text articles, and abstracted data. Additional data were sought from authors. Random-effects meta-analyses were performed using incidence data (statistically adjusted for confounders and crude rates). Findings: A total of 1658 unique citations were screened, and 62 full-text articles were reviewed, including 5 studies. Three studies included exclusively microcarcinomas and 2 included tumors up to 2 cm in maximal diameter. The mean age of participants was 51.0 to 55.2 years in 4 studies reporting this value. The mean or median follow-up was 5 years or more in 3 studies and approximately 2 years in 2 studies. The pooled risk ratio for tumor growth of 3 mm or more in maximal diameter in individuals aged 40 to 50 years compared with younger individuals was 0.51 when adjusted for confounders (95% CI, 0.29-0.89; 1619 patients, 2 studies), and the unadjusted risk ratio of this outcome for individuals 40 years or older was 0.55 (95% CI, 0.36-0.82; 2097 patients, 4 studies). In adults aged 40 to 45 years, the unadjusted risk ratio for any tumor volume increase compared with younger individuals was 0.65 (95% CI, 0.51-0.83; 1232 patients, 4 studies). The pooled risk ratio for incident nodal metastases in individuals 40 years or older was 0.22 (95% CI, 0.10-0.47; 1806 patients, 3 studies); however, in a secondary analysis, the risk difference was not significantly different. There was no statistically significant heterogeneity in any of the meta-analyses. There were no thyroid cancer-related deaths nor incident distant metastases. Conclusions and Relevance: This study suggests that older age may be associated with a reduced risk of primary papillary thyroid carcinoma tumor growth under active surveillance. Incident metastatic disease is uncommon during active surveillance.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
我是老大的应助被寒冷鸭子采纳,获得10
刚刚
1秒前
甜美的尔柳完成签到,获得积分10
1秒前
1秒前
长风完成签到,获得积分10
1秒前
Ava的应助被xie采纳,获得10
2秒前
pandaheld完成签到,获得积分10
2秒前
Chelsea发布了新的文献求助20
3秒前
3秒前
3秒前
superchen完成签到,获得积分10
3秒前
科研通AI6.3的应助被爱笑丹云采纳,获得10
4秒前
斯文败类的应助被小杨采纳,获得10
4秒前
4秒前
hhh完成签到,获得积分10
5秒前
5秒前
爱科研的小民完成签到,获得积分10
5秒前
在望的应助被科小白采纳,获得10
5秒前
Owen的应助被务实的忆雪采纳,获得10
5秒前
风吹麦浪发布了新的文献求助10
6秒前
6秒前
风吹麦浪发布了新的文献求助10
6秒前
6秒前
wang5945发布了新的文献求助10
6秒前
7秒前
wwj完成签到,获得积分20
7秒前
howay发布了新的文献求助10
7秒前
8秒前
研友_VZG7GZ的应助被AKTAO采纳,获得10
8秒前
8秒前
小田儿完成签到 ,获得积分10
8秒前
cua完成签到,获得积分10
8秒前
9秒前
9秒前
zhang关注了科研通微信公众号
9秒前
丘比特的应助被啊啊啊啊采纳,获得10
9秒前
风吹麦浪发布了新的文献求助10
9秒前
10秒前
cdercder的应助被ahe采纳,获得10
10秒前
江南脆饼发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181279
求助须知:如何正确求助?哪些是违规求助? 9571198
关于积分的说明 21817073
捐赠科研通 7777612
什么是DOI,文献DOI怎么找? 3433454
关于科研通互助平台的介绍 2557692
邀请新用户注册赠送积分活动 2479519